Back to the search results

Klinikverbund Allgäu gGmbH - Klinik Immenstadt

Im Stillen 2-3
87509 Immenstadt

Phone: 08323-910-0
Fax: 08323-910-260
Mail: ed.ueaglla-dnubrevkinilk@ofni

  • Number of beds: 166
  • Number of specialist departments: 11
  • Number of inpatient cases: 10.644
  • Number of outpatient cases: 16.216
  • Hospital owners: Klinikverbund Allgäu gGmbH
  • Type of provider: öffentlich
External comparative quality assurance
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung yes
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Quantity performed 1
Exception? No exception
Der Operateur als auch das Anästhesie- und OP-Personal sind standortübergreifend (Klinik Immenstadt und Oberstdorf) organisiert und an beiden Klinikstandorten tätig. In Obersdorf wurden 2022 insg. 452 Kniegelenk-Totalendoprothesen erbracht. Der Operateur gehört zu den Hauptoperateuren in Oberstdorf. Insofern ist die erforderliche Expertise sowie Erfahrung gegeben. Darüber hinaus wird die Leistung ab 2024 wieder regelhaft in Immenstadt angeboten. Die erforderliche Berechtigung dazu wurde erteilt.
Overall result forecast presentation: yes
Quantity performed reporting year: 1
Quantity forecast year: 1
Examination by state associations? no
Exemption? yes
Result of the examination by the federal state authorities? no
Transitional arrangement? no
No. Explanation
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ27 Guideline on quality assurance measures for inpatient care with bronchoscopic lung volume reduction procedures for severe emphysema (QS Guideline bronchoscopic LVR /QS-RL BLVR)
CQ25 Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: no
Number Group
50 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
10 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
9 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Training in other healing professions
Comment

Comment

Comment

Comment

Comment

Comment

Andreas Gröbl

Patientenfürsprecher

Im Stillen 2-3
87509 Immenstadt

Phone: 08323 -910-195
Mail: ed.ueaglla-dnubrevkinilk@rehcerpsreufnetneitap

Tim Herrmann

Beschwerdemanager

Im Stillen 2-3
87509 Immenstadt

Phone: 08323 -910-8381
Mail: ed.ueaglla-dnubrevkinilk@nnamrreh.mit

Jeannine Hsain

Beschwerdemanager

Im Stillen 2-3
87509 Immenstadt

Phone: 08323 -910-8971
Mail: ed.ueaglla-dnubrevkinilk@niash.eninnaej

Jeannine Hsain

Leiterin Organisationsentwicklung

Im Stillen 2-3
87509 Immenstadt

Phone: 08323 -910-8971
Mail: ed.ueaglla-dnubrevkinilk@niash.eninnaej

Prof. Dr. med. Ricardo Felberbaum

Chefarzt Frauenheilkunde und Geburtshile Kliniken Kempten und Immenstadt

Im Stillen 2-3
87509 Immenstadt

Phone: 0831 -530-3393
Mail: ed.ueaglla-dnubrevkinilk@muabreblef.odracir

Arndt Botzenhardt

Apotheker

Im Stillen 2-3
87509 Immenstadt

Phone: 08323 -987-587
Mail: ed.tdrahneztob-rekehtopa@gnugrosrevkinilk

Tim Herrmann

Beschwerdemanager

Im Stillen 2-3
87509 Immenstadt

Phone: 08323 -910-8381
Mail: ed.ueaglla-dnubrevkinilk@nnamrreh.mit

Jeannine Hsain

Beschwerdemanager

Im Stillen 2-3
87509 Immenstadt

Phone: 08323 -910-8971
Mail: ed.ueaglla-dnubrevkinilk@niash.eninnaej

Im Stillen 2-3
87509 Immenstadt

Phone: 08323-910-0
Fax: 08323-910-260
Mail: ed.ueaglla-dnubrevkinilk@ofni

Matthias Ecker

Pflegedienstleiter

Im Stillen 2-3
87509 Immenstadt

Phone: 08323 -910-274
Mail: ed.ueaglla-dnubrevkinilk@rekce.saihttam

Florian Leier

Pflegedienstleiter

Im Stillen 2-3
87509 Immenstadt

Phone: 08323 -910-8313
Mail: ed.ueaglla-dnubrevkinilk@reiel.nairolf

Bernhard Heberle

Kaufmännischer Leiter Finanzen

Im Stillen 2-3
87509 Immenstadt

Phone: 08323 -910-243
Mail: ed.ueaglla-dnubrevkinilk@elrebeh.drahnreb

Julia Eggel

örtliche Betriebsleitung

Im Stillen 2-3
87509 Immenstadt

Phone: 08323 -910-148
Mail: ed.ueaglla-dnubrevkinilk@legge.ailuj

Jochen Duss

Kaufmännischer Leiter Infrastruktur

Im Stillen 2-3
87509 Immenstadt

Phone: 0831 -530-3550
Mail: ed.ueaglla-dnubrevkinilk@ssud.nehcoj

Markus Treffler

Klinikleitung

Im Stillen 2-3
87509 Immenstadt

Phone: 08323 -910-244
Mail: ed.ueaglla-dnubrevkinilk@relffert.sukram

Andreas Ruland

Standort-Geschäftsführer Klinik Immenstadt

Im Stillen 2-3
87509 Immenstadt

Phone: 0831 -530-3216
Mail: ed.ueaglla-dnubrevkinilk@dnalur.saerdna

Markus Treffler

Geschäftsführer

Im Stillen 2-3
87509 Immenstadt

Phone: 08323 -910-245
Mail: ed.ueaglla-dnubrevkinilk@relffert.sukram

Dr. med. Martin Fiedermutz

Ärztlicher Direktor

Im Stillen 2-3
87509 Immenstadt

Phone: 08323 -910-8808
Mail: ed.ueaglla-dnubrevkinilk@ztumredeif.nitram

IK: 260970173

Location number: 771223000

Old location number: 771223000